Radiation Dose Management Market By Solution (Software and Services), By Modality (Radiography, Computed Tomography, Mammography, Fluoroscopy & Interventional Imaging, Nuclear Medicine Scans and Others) - Growth, Future Prospects & Competitive Analysis, 2019 – 2027

Published By: Brisk Insights | Published On: Jun 15, 2021

 

Industry Outlook

 

The radiation dose management market is set to reach US$ 1,349.5 Mn by 2027 from US$ 179.0 Mn in 2018 projecting rapid growth at a compounded annual growth rate (CAGR) of 25.8% during the forecast period from 2019 to 2027.  The major drivers associated with radiation dose management market are rising prevalence of chronic ailment and stringent regulatory norm related to safety of radiation exposure in patients. Significant rise in diagnostic screening centers and rising public health awareness further propel the radiation dose management market.

 

"Capability to design robust radiation safety program and efficient collection of clinical data pertaining to patient disease screening increased the demand for software solutions"

 

In the present scenario the software solutions are spearheading the solution segment for radiation dose management market. Prominent features associated such as capability to design robust radiation safety program ensuring negligible side effects in patients exposed to radiation therapy increases the demand for software solutions. Efficient collection of clinical data pertaining to patient disease diagnosis further propels the market growth for software solutions. Services are keen to register steady growth in the near future owing to rising public health awareness resulting in early disease diagnosis and significant rise in diagnostic centers worldwide.

 

"Ease of operation, effective radiation dose monitoring and quick acquisition of precise images increases the popularity of computed tomography over other modalities"

 

Computed tomography is currently leading the modality segment for radiation dose management market. The inherent features associated with computed tomography are elimination of overlapping structures making the internal anatomy more apparent and visible. It guides the surgeons during critical surgical procedures, ease of operation, effective radiation dose monitoring and quick turnaround time are the key attributes which increase sits popularity over other modalities. Nuclear medicine scans have gained tremendous attention in the last decade owing to its capability in understanding the cellular metabolism in chronic disease, thorough investigation of tumor or infection and its spread in the body. It is a useful tool to validate whether the ongoing treatment protocol is effective or needs change.

 

"Stringent regulatory norms regarding patient safety receiving radiation therapy and rising prevalence of chronic disease drive the market growth in North America"

 

North America holds the largest market share of 36% in the regional segment for radiation dose management market. The chief parameters consolidating its market growth in North America are stringent norms imposed by healthcare agencies in patients receiving radiation therapy and rising prevalence of chronic disease resulting in early disease diagnosis. Favorable reimbursement scenario pertaining to utilization of radiation dose therapy further bolsters the market growth in the region. Europe represents 29.5% market share and is the second largest regional market owing to domicile of key players such as Bayer AG, Philips Healthcare, Sectra AB etc. promote the market performance of radiation dose management. Asia Pacific with a market share of 22% is keen to register outstanding growth over the forecast period on account of developing healthcare infrastructure and increasing medical tourism.

 

Historical & Forecast Period

 

This research report presents the analysis of each segment from 2017 to 2027 considering 2018 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2019 to 2027

 

Report Scope by Segments

 

The market segmentation for the scope of report is done as by solution, modality and geography.

 

ATTRIBUTE DETAILS
Research Period  2017-2027
Base Year 2018
Forecast Period  2019-2027
Historical Year  2017
Unit  USD Million
Segmentation

 By Solution (2017–2027; US$ Mn)
 • Software
 • Services

 By Indication (2017–2027; US$ Mn)
 • Radiography
 • Computed Tomography
 • Mammography
 • Fluoroscopy & Interventional Imaging
 • Nuclear Medicine Scans
 • Others

 Geography Segment (2017–2027; US$ Mn)
 • North America (U.S., Canada)
 • Europe (U.K., Germany, Rest of Europe)
 • Asia Pacific (China, Japan, Rest of Asia Pacific)
 • Latin America (Brazil, Mexico, Rest of Latin America)
 • Middle East and Africa (GCC, Rest of MEA)

 

Medical device manufacturers specializing in radiation dose management solutions are Bayer AG, Fujifilm Holdings Corporation, Bracco Imaging S.P.A., GE Healthcare, Philips Healthcare, Medsquare, Novarad Corporation, Sectra AB, Pacshealth, LLC. and Qaelum N.V.

 

Key questions answered in this report

 

  • Which major medical device manufacturers are providing radiation dose management solutions?
  • What are the latest acquisition and mergers taking place in the radiation dose management market?
  • What are the regulatory guidelines sanctioned for the safety pertaining to radiation therapy?
  • Which factors promote software solutions market growth?
  • What is the principle pertaining to nuclear medicine scans and its application in disease diagnosis and treatment validation?
  • Which parameters are responsible for the market dominance of North America regional segment in radiation dose management market?

 

Chapter 1. Preface


1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

 

Chapter 2. Executive Summary


2.1. Global RDM Market Portraiture
2.2. Global RDM Market, by Solution, 2018 (US$ Mn)
2.3. Global RDM Market, by Modality, 2018 (US$ Mn)
2.4. Global RDM Market, by Geography, 2018 (US$ Mn)

 

Chapter 3. Radiation Dose Management (RDM) Market: Dynamics and Future Outlook


3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2018
3.6. Competitive Analysis: Global RDM Market, by Key Players, 2018

 

Chapter 4. Global Radiation Dose Management (RDM) Market, by Solution


4.1. Overview
4.2. Software
4.3. Services

 

Chapter 5. Global Radiation Dose Management (RDM) Market, by Modality


5.1. Overview
5.2. Radiography
5.3. Computed Tomography
5.4. Mammography
5.5. Fluoroscopy & Interventional Imaging
5.6. Nuclear Medicine Scans
5.7. Others

 

Chapter 6. Global Radiation Dose Management (RDM) Market, by Geography


6.1. Overview
6.2. North America RDM Market Analysis, 2017 – 2027
6.2.1. North America RDM Market, by Solution, 2017 – 2027 (US$ Mn)
6.2.2. North America RDM Market, by Modality, 2017 – 2027 (US$ Mn)
6.2.3. North America RDM Market, by Country, 2017 – 2027 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe RDM Market Analysis, 2017 – 2027
6.3.1. Europe RDM Market, by Solution, 2017 – 2027 (US$ Mn)
6.3.2. Europe RDM Market, by Modality, 2017 – 2027 (US$ Mn)
6.3.3. Europe RDM Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific RDM Market Analysis, 2017 – 2027
6.4.1. Asia Pacific RDM Market, by Solution, 2017 – 2027 (US$ Mn)
6.4.2. Asia Pacific RDM Market, by Modality, 2017 – 2027 (US$ Mn)
6.4.3. Asia Pacific RDM Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America RDM Market Analysis, 2017– 2027
6.5.1. Latin America RDM Market, by Solution, 2017 – 2027 (US$ Mn)
6.5.2. Latin America RDM Market, by Modality, 2017 – 2027 (US$ Mn)
6.5.3. Latin America RDM Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East and Africa RDM Market Analysis, 2017 – 2027
6.6.1. MEA RDM Market, by Solution, 2017 – 2027 (US$ Mn)
6.6.2. MEA RDM Market, by Modality, 2017 – 2027 (US$ Mn)
6.6.3. MEA RDM Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

 

Chapter 7. Company Profiles


7.1. Bayer AG
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Bracco Imaging S.P.A.
7.3. Fujifilm Holdings Corporation
7.4. GE Healthcare
7.5. Medsquare
7.6. Novarad Corporation
7.7. Pacshealth, LLC.
7.8. Philips Healthcare
7.9. Qaelum N.V.
7.10. Sectra AB

* Here we are using RDM as a short form of Radiation Dose Management

TABLE 1 Global Radiation Dose Management (RDM) Market Portraiture
TABLE 2 Global RDM Market, by Solution, 2017 – 2027 (US$ Mn)
TABLE 3 Global RDM Market , by Modality, 2017 – 2027 (US$ Mn)
TABLE 4 Global RDM Market, by Geography, 2017 – 2027 (US$ Mn)
TABLE 5 North America RDM Market, by Solution, 2017 – 2027 (US$ Mn)
TABLE 6 North America RDM Market, by Modality, 2017 – 2027 (US$ Mn)
TABLE 7 North America RDM Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 8 Europe RDM Market, by Solution, 2017 – 2027 (US$ Mn)
TABLE 9 Europe RDM Market, by Modality, 2017 – 2027 (US$ Mn)
TABLE 10 Europe RDM Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 11 Asia Pacific RDM Market, by Solution, 2017 – 2027 (US$ Mn)
TABLE 12 Asia Pacific RDM Market, by Modality, 2017 – 2027 US$ Mn)
TABLE 13 Asia Pacific RDM Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 14 Latin America RDM Market, by Solution, 2017 – 2027 (US$ Mn)
TABLE 15 Latin America RDM Market, by Modality, 2017 – 2027 (US$ Mn)
TABLE 16 Latin America RDM Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 17 Middle East and Africa RDM Market, by Solution, 2017 – 2027 (US$ Mn)
TABLE 18 Middle East and Africa RDM Market, by Modality, 2017 – 2027 (US$ Mn)
TABLE 19 Middle East and Africa RDM Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 20 Bayer AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Bracco Imaging S.P.A.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Fujifilm Holdings Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 GE Healthcare: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Medsquare: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Novarad Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 Pacshealth, LLC.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Philips Healthcare: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 Qaelum N.V.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Sectra AB: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)

FIG. 1 Radiation Dose Management (RDM) Market: Research Methodology
FIG. 2 RDM: Market Segmentation
FIG. 3 Global RDM Market, by Solution, 2018 (US$ Mn)
FIG. 4 Global RDM Market, by Modality, 2018 (US$ Mn)
FIG. 5 Global RDM Market, by Geography, 2018 (US$ Mn)
FIG. 6 Attractive Investment Proposition: by Geography, 2018
FIG. 7 Competitive Analysis: Global RDM Market, by Key Players, 2018
FIG. 8 Global Software Solution Market for RDM, 2017 – 2027 (US$ Mn)
FIG. 9 Global Services Solution Market for RDM, 2017 – 2027 (US$ Mn)
FIG. 10 Global Radiography Market for RDM, 2017 – 2027 (US$ Mn)
FIG. 11 Global Computed Tomography Market for RDM, 2017 – 2027 (US$ Mn)
FIG. 12 Global Mammography Market for RDM, 2017 – 2027 (US$ Mn)
FIG. 13 Global Fluoroscopy & Interventional Imaging Market for RDM, 2017 – 2027 (US$ Mn)
FIG. 14 Global Nuclear Medicine Scans Market for RDM, 2017 – 2027 (US$ Mn)
FIG. 15 Global Other Modality Market for RDM, 2017 – 2027 (US$ Mn)
FIG. 16 U.S. RDM Market, 2017 – 2027 (US$ Mn)
FIG. 17 Canada RDM Market, 2017 – 2027 (US$ Mn)
FIG. 18 U.K. RDM Market, 2017 – 2027 (US$ Mn)
FIG. 19 Germany RDM Market, 2017 – 2027 (US$ Mn)
FIG. 20 Rest of Europe RDM Market, 2017 – 2027 (US$ Mn)
FIG. 21 China RDM Market, 2017 – 2027 (US$ Mn)
FIG. 22 Japan RDM Market, 2017 – 2027 (US$ Mn)
FIG. 23 Rest of Asia Pacific RDM Market, 2017 – 2027 (US$ Mn)
FIG. 24 Brazil RDM Market, 2017 – 2027 (US$ Mn)
FIG. 25 Mexico RDM Market, 2017 – 2027 (US$ Mn)
FIG. 26 Rest of Latin America RDM Market, 2017 – 2027 (US$ Mn)
FIG. 27 GCC RDM Market, 2017 – 2027 (US$ Mn)
FIG. 28 Rest of MEA RDM Market, 2017 – 2027 (US$ Mn)

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)